View Cart  

Compounder’s Growth Plans Failed to Elicit FDA Clamp Down

A A
Congressional investigators have compiled a history of inspections at the New England Compounding Center (NECC) in Framingham, Mass., that shows regulators considered placing the compounding pharmacy under tighter control, but did not.

To View This Article:

Login

Subscribe To Drug Industry Daily